Advances in molecular signaling mechanisms of β-phenethyl isothiocyanate antitumor effects.

Abstract

β-Phenethyl isothiocyanate (PEITC) is an important phytochemical from cruciferous vegetables and is being evaluated for chemotherapeutic activity in early phase clinical trials. Moreover, studies in cell culture and in animals found that the anticarcinogenic activities of PEITC involved all the major stages of tumor growth: initiation, promotion, and progression. A number of mechanisms have been proposed for the chemopreventive activities of this compound. Here, we focus on the major molecular signaling pathways for the anticancer activities of PEITC. These include (1) activation of apoptosis pathways; (2) induction of cell cycle arrest; and (3) inhibition of the survival pathways. Furthermore, we also discussed the regulation of drug-metabolizing enzymes, including cytochrome P450s, metabolizing enzymes, and multidrug resistance.

• Authors: Chong-Zhen Qin, Xue Zhang, Lan-Xiang Wu, Chun-Jie Wen, Lei Hu, Qiao-Li Lv, Dong-Ya Shen, Hong-Hao Zhou
• Journal: Journal of agricultural and food chemistry (J Agric Food Chem) Vol. 63 Issue 13 Pg. 3311-22 (Apr 08 2015) ISSN: 1520-5118 [Electronic] United States
• PMID: 25798652 (Publication Type: Journal Article, Review)

Chemical References

• Anticarcinogenic Agents
• Antineoplastic Agents
• Isothiocyanates
• NF-kappa B
• phenethyl isothiocyanate

Topics

• Animals
• Anticarcinogenic Agents (pharmacology)
• Antineoplastic Agents (pharmacology)
• Apoptosis (drug effects)
• Cell Cycle (drug effects)
• Cell Line, Tumor
• Endoplasmic Reticulum Stress (drug effects)
• Humans
• Isothiocyanates (pharmacology)
• Male
• Mitochondria (drug effects)
• NF-kappa B
• Signal Transduction (drug effects)